Cellectar Biosciences, Inc.

CLRB ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2009 FY2008 FY2007 FY2006 FY2005 FY2004 FY2003 FY2002
Assets
Cash & Equivalents $980.1K $0
Accounts Receivable
Inventory
Total Current Assets
Property, Plant & Equipment
Goodwill
Intangible Assets (Excl. Goodwill)
Total Assets
Liabilities
Accounts Payable
Total Current Liabilities
Long-Term Debt
Total Liabilities
Stockholders' Equity
Retained Earnings
Total Stockholders' Equity $4.1M $9.8M $2.5M $6.5M $400.2K $46.2K $388.9K $599.4K
← Newer Page 3 of 3 Older →